VanEck Healthcare TruSector ETF (TRUH) Holdings
TRUH holdings summary
as of Oct 25, 2026- Holdings
- 60 positions listed
- Top 10 weight
- 60.9% of net assets
- Effective holdings
- 18 equal-weight equivalent
- Largest holding
- LLY 15.90% Eli Lilly and Company
- Annual turnover
- — of the portfolio traded
All TRUH holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | Healthcare | 15.90% | $100,520.40 | $1.12T | 42.2 |
| 2 | JNJ | Johnson & Johnson | Healthcare | 9.46% | $59,808.91 | $615.87B | 38.8 |
| 3 | ABBV | AbbVie Inc. | Healthcare | 8.13% | $51,394.97 | $504.37B | 80.6 |
| 4 | UNH | UnitedHealth Group Incorporated | Healthcare | 5.93% | $37,507.84 | $360.32B | 25.8 |
| 5 | MRK | Merck & Co., Inc. | Healthcare | 5.32% | $33,638.05 | $360.08B | 115.8 |
| 6 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 3.95% | $24,982.68 | $255.13B | 37.1 |
| 7 | AMGN | Amgen Inc. | Healthcare | 3.59% | $22,696.71 | $233.82B | 26.9 |
| 8 | GILD | Gilead Sciences, Inc. | Healthcare | 3.08% | $19,485.47 | $193.67B | — |
| 9 | ABT | Abbott Laboratories | Healthcare | 2.82% | $17,811.28 | $181.50B | 33.8 |
| 10 | PFE | Pfizer Inc. | Healthcare | 2.72% | $17,186.22 | $168.60B | 38.9 |
| 11 | ISRG | Intuitive Surgical, Inc. | Healthcare | 2.41% | $15,231.42 | $150.74B | 48.9 |
| 12 | DHR | Danaher Corporation | Healthcare | 2.18% | $13,752.52 | $161.01B | 40.8 |
| 13 | BMY | Bristol-Myers Squibb Company | Healthcare | 2.02% | $12,788.70 | $122.05B | 13.2 |
| 14 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 1.94% | $12,235.69 | $126.66B | 28.9 |
| 15 | CVS | CVS Health Corporation | Healthcare | 1.91% | $12,054.94 | $118.13B | 24.3 |
| 16 | MDT | Medtronic plc | Healthcare | 1.90% | $12,020.18 | $121.20B | 23.3 |
| 17 | SYK | Stryker Corporation | Healthcare | 1.75% | $11,038.67 | $113.02B | 30.5 |
| 18 | MCK | McKesson Corporation | Healthcare | 1.73% | $10,923.01 | $117.15B | 26.9 |
| 19 | ELV | Elevance Health Inc. | Healthcare | 1.43% | $9,059.85 | $92.88B | 19.0 |
| 20 | CI | Cigna Corporation | Healthcare | 1.27% | $8,053.69 | $79.88B | 12.5 |
| 21 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 1.18% | $7,429.27 | $81.41B | 19.6 |
| 22 | MRNA | Moderna, Inc. | Healthcare | 1.12% | $7,082.29 | $87.04B | — |
| 23 | HCA | HCA Healthcare, Inc. | Healthcare | 1.01% | $6,383.92 | $99.34B | 15.4 |
| 24 | BSX | Boston Scientific Corporation | Healthcare | 0.97% | $6,125.43 | $64.33B | 18.0 |
| 25 | COR | Cencora | Healthcare | 0.94% | $5,969.96 | $65.06B | 25.3 |
| 26 | CAH | Cardinal Health, Inc. | Healthcare | 0.92% | $5,834.08 | $58.83B | 35.1 |
| 27 | HUM | Humana Inc. | Healthcare | 0.83% | $5,242.51 | $49.61B | 39.1 |
| 28 | BDX | Becton, Dickinson and Company | Healthcare | 0.83% | $5,230.51 | $52.23B | 44.6 |
| 29 | EW | Edwards Lifesciences Corporation | Healthcare | 0.81% | $5,132.55 | $49.92B | 51.5 |
| 30 | IQV | IQVIA Holdings Inc. | Healthcare | 0.74% | $4,690.14 | $43.93B | 33.2 |
| 31 | VEEV | Veeva Systems Inc. | Healthcare | 0.74% | $4,666.12 | $50.25B | 50.9 |
| 32 | A | Agilent Technologies, Inc. | Healthcare | 0.73% | $4,640.21 | $48.77B | 34.1 |
| 33 | IDXX | IDEXX Laboratories, Inc. | Healthcare | 0.70% | $4,435.44 | $44.20B | 39.8 |
| 34 | WAT | Waters Corporation | Healthcare | 0.63% | $4,009.47 | $42.90B | 110.6 |
| 35 | ILMN | Illumina, Inc. | Healthcare | 0.62% | $3,904.55 | $39.64B | 49.0 |
| 36 | RMD | ResMed Inc. | Healthcare | 0.58% | $3,670.08 | $33.61B | 22.9 |
| 37 | BIIB | Biogen Inc. | Healthcare | 0.56% | $3,567.69 | $34.37B | 41.3 |
| 38 | MTD | Mettler-Toledo International Inc. | Healthcare | 0.54% | $3,428.02 | $32.51B | 36.6 |
| 39 | ZTS | Zoetis Inc. | Healthcare | 0.53% | $3,342.06 | $32.80B | 13.1 |
| 40 | CNC | Centene Corporation | Healthcare | 0.52% | $3,279.49 | $34.16B | — |
| 41 | GEHC | GE HealthCare Technologies Inc. | Healthcare | 0.48% | $3,064.61 | $31.42B | 16.0 |
| 42 | DXCM | DexCom, Inc. | Healthcare | 0.45% | $2,841.51 | $32.47B | 34.1 |
| 43 | WST | West Pharmaceutical Services, Inc. | Healthcare | 0.43% | $2,697.41 | $27.03B | 49.4 |
| 44 | DGX | Quest Diagnostics Incorporated | Healthcare | 0.42% | $2,634.21 | $25.94B | 24.6 |
| 45 | LH | Laboratory Corporation of America Holdings | Healthcare | 0.40% | $2,553.95 | $25.79B | 26.3 |
| 46 | STE | STERIS plc | Healthcare | 0.34% | $2,139.98 | $21.71B | 27.2 |
| 47 | VTRS | Viatris Inc. | Healthcare | 0.33% | $2,081.21 | $21.43B | — |
| 48 | INCY | Incyte Corporation | Healthcare | 0.31% | $1,952.28 | $22.92B | 14.4 |
| 49 | CRL | Charles River Laboratories International, Inc. | Healthcare | 0.29% | $1,821.45 | $14.46B | — |
| 50 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | 0.28% | $1,792.38 | $18.12B | 23.1 |
| 51 | RVTY | Revvity, Inc. | Healthcare | 0.27% | $1,690.62 | $17.03B | 73.0 |
| 52 | BAX | Baxter International Inc. | Healthcare | 0.21% | $1,340.49 | $13.07B | — |
| 53 | COO | The Cooper Companies, Inc. | Healthcare | 0.19% | $1,199.55 | $11.02B | 19.9 |
| 54 | SOLV | Solventum Corporation | Healthcare | 0.18% | $1,167.95 | $14.61B | 10.5 |
| 55 | TECH | Bio-Techne Corporation | Healthcare | 0.18% | $1,155.31 | $11.38B | 62.6 |
| 56 | PODD | Insulet Corporation | Healthcare | 0.16% | $1,021.33 | $9.79B | 26.4 |
| 57 | UHS | Universal Health Services, Inc. | Healthcare | 0.15% | $960.02 | $10.91B | 7.6 |
| 58 | ALGN | Align Technology, Inc. | Healthcare | 0.15% | $939.80 | $10.46B | 25.6 |
| 59 | HSIC | Henry Schein, Inc. | Healthcare | 0.12% | $787.48 | $9.63B | 25.2 |
| 60 | DVA | DaVita Inc. | Healthcare | 0.09% | $540.37 | $11.95B | 15.8 |
Weights as a percentage of net assets. Value held = weight × net assets ($632,009.00). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
TRUH sector breakdown
Sum of the weights of the holdings in each sector.
TRUH top industries
TRUH overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| XLV | Health Care Select Sector SPDR Fund | 98.2% | 60 of 60 | 0.09% |
| IYH | iShares U.S. Healthcare ETF | 90.3% | 55 of 99 | 0.39% |
| FHLC | Fidelity MSCI Health Care ETF | 86.3% | 60 of 334 | 0.07% |
| VHT | Vanguard Health Care ETF | 84.9% | 60 of 406 | 0.10% |
| IXJ | iShares Global Healthcare ETF | 73.1% | 60 of 106 | 0.42% |
| RXL | ProShares Ultra Health Care | 63.0% | 60 of 61 | 0.93% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the TRUH portfolio
VanEck Healthcare TruSector ETF holds 60 positions. The ten largest make up 60.9% of the fund and the top 50 98.7%, so it behaves like a portfolio of about 18 equally weighted stocks. The biggest positions are Eli Lilly and Company (15.90%), Johnson & Johnson (9.46%), AbbVie Inc. (8.13%), UnitedHealth Group Incorporated (5.93%), Merck & Co., Inc. (5.32%).
By sector, Healthcare is 100.4%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: TRUH chart, TRUH dividends, TRUH valuation, TRUH overview.
TRUH holdings FAQ
How many holdings does TRUH have?
TRUH holds 60 positions as of October 25, 2026.
What are the top 10 holdings of TRUH?
The ten largest holdings are Eli Lilly and Company (15.90%), Johnson & Johnson (9.46%), AbbVie Inc. (8.13%), UnitedHealth Group Incorporated (5.93%), Merck & Co., Inc. (5.32%), Thermo Fisher Scientific Inc. (3.95%), Amgen Inc. (3.59%), Gilead Sciences, Inc. (3.08%), Abbott Laboratories (2.82%), Pfizer Inc. (2.72%). Together they are 60.9% of the fund.
What percentage of TRUH is Eli Lilly and Company?
Eli Lilly and Company is the largest holding at 15.90% of net assets, about $100,520.40 of the fund's $632,009.00.
How concentrated is TRUH?
The top 10 holdings are 60.9% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) TRUH behaves like a portfolio of about 18 equally weighted stocks.